US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PomDoctor

0.2546

+0.01827.70%

Post-market: 0.2313-0.0233-9.15%16:41 EST

Volume:647.02K

Turnover:162.54K

Market Cap:30.16M

PE:-0.46

High:0.2650

Open:0.2380

Low:0.2300

Close:0.2364

52wk High:6.43

52wk Low:0.2050

Shares:118.44M

Float Shares:5.00M

Volume Ratio:2.70

T/O Rate:12.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5490

EPS(LYR):-0.5188

ROE:--

ROA:-32.56%

PB:-0.09

PE(LYR):-0.49

Loading ...

Overview Company News Filings

Pomdoctor Limited Announces Receipt of Nasdaq Notice

THOMSON REUTERS

Press Release: POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies

Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative

Simply Wall St.

Pomdoctor H1 EPS $(1.60), Sales $24.400M

Pomdoctor Ltd. HY net loss attributable to shareholders at USD 66.7 million, down over six times

Press Release: POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results

PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules

Benzinga_recent_news

US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut

Stock Track | PomDoctor Plunges 7.90% After Hours Following Volatile IPO Debut

Stock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut

Stock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO

Stock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains

Stock Track | PomDoctor Plummets 6.25% After Initial IPO Surge, Investors Reassess

Stock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO

Pomdoctor Prices Roughly $20 Million IPO

MT Newswires Live

BRIEF-Pomdoctor Limited Announces Pricing Of Initial Public Offering

Pomdoctor Ltd: Approved for Listing on Nasdaq Under Ticker Symbol "Pom"

THOMSON REUTERS

Pomdoctor Limited Announces Pricing of Initial Public Offering

THOMSON REUTERS

Pomdoctor Ltd - Pricing of IPO of 5,000,004 Adss at a Public Offering Price of US$4.00 per Ads

THOMSON REUTERS

Polyplastics' DURAST (R) Fine Powder Technology Unleashes New Manufacturing Possibilities for Engineering Plastics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/POM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"POM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"POM\",,,,,undefined,":{"symbol":"POM","market":"US","secType":"STK","nameCN":"PomDoctor","latestPrice":0.2546,"timestamp":1771016400000,"preClose":0.2364,"halted":0,"volume":647019,"hourTrading":{"tag":"盘后","latestPrice":0.2313,"preClose":0.2546,"latestTime":"16:41 EST","volume":3830,"amount":884.5278,"timestamp":1771018903263,"change":-0.0233,"changeRate":-0.091516,"amplitude":0.096622},"delay":0,"changeRate":0.07698815566835869,"floatShares":5000004,"shares":118444560,"eps":-0.549017,"marketStatus":"Market Closed","change":0.0182,"latestTime":"02-13 16:00:00 EST","open":0.238,"high":0.265,"low":0.23,"amount":162539.48052396,"amplitude":0.148054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.549017,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":0.2364,"preHourTrading":{"tag":"盘前","latestPrice":0.2364,"preClose":0.24,"latestTime":"09:04 EST","volume":5480,"amount":1295.8119244,"timestamp":1770991465743,"change":-0.0036,"changeRate":-0.015,"amplitude":0.056667},"postHourTrading":{"tag":"盘后","latestPrice":0.2313,"preClose":0.2546,"latestTime":"16:41 EST","volume":3830,"amount":884.5278,"timestamp":1771018903263,"change":-0.0233,"changeRate":-0.091516,"amplitude":0.096622},"volumeRatio":2.700471974596292},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"POM\",,,,,undefined,":{"symbol":"POM","floatShares":5000004,"roa":"-32.56%","roe":"--","lyrEps":-0.518771,"volumeRatio":2.700471974596292,"shares":118444560,"dividePrice":0,"high":0.265,"amplitude":0.148054,"preClose":0.2364,"low":0.23,"week52Low":0.205,"pbRate":"-0.09","psRate":"0.57","week52High":6.43,"institutionHeld":0.6205,"latestPrice":0.2546,"eps":-0.549017,"divideRate":0,"volume":647019,"delay":0,"ttmEps":-0.549017,"open":0.238,"prevYearClose":0.2949,"prevWeekClose":0.231,"prevMonthClose":0.2311,"prevQuarterClose":0.2949,"fiveDayClose":0.231,"twentyDayClose":0.3064,"sixtyDayClose":4.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/POM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"POM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"POM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/POM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"POM","date":"2026-02-13","current":-0.463738,"percent":0.920455,"low":-35.821387,"twenty":-27.413697,"median":-4.901837,"eighty":-1.639593,"high":-1.21961,"avg":-14.616408,"sd":13.236492,"marketCap":27999733},"quantilePoints":[{"date":"2025-10-10","current":-28.08946,"twenty":-26.346384,"median":-23.73177,"eighty":-12.43381,"marketCap":564969251},{"date":"2025-10-17","current":-25.958938,"twenty":-27.529376,"median":-25.953316,"eighty":-24.492433,"marketCap":522330062},{"date":"2025-10-24","current":-27.125928,"twenty":-27.238055,"median":-25.772572,"eighty":-24.836146,"marketCap":546018500},{"date":"2025-10-31","current":-32.013232,"twenty":-27.923178,"median":-26.542433,"eighty":-25.229622,"marketCap":645509940},{"date":"2025-11-07","current":-35.821387,"twenty":-31.941418,"median":-27.312807,"eighty":-25.43938,"marketCap":721312943},{"date":"2025-11-14","current":-20.985101,"twenty":-31.755441,"median":-27.438919,"eighty":-25.43938,"marketCap":424023043},{"date":"2025-11-21","current":-26.081236,"twenty":-31.546612,"median":-27.125928,"eighty":-25.185662,"marketCap":525883328},{"date":"2025-11-28","current":-25.273189,"twenty":-31.358539,"median":-26.69732,"eighty":-25.180844,"marketCap":511670265},{"date":"2025-12-05","current":-26.661858,"twenty":-30.715676,"median":-26.679589,"eighty":-25.208091,"marketCap":561415985},{"date":"2025-12-12","current":-2.158073,"twenty":-31.053988,"median":-26.69732,"eighty":-25.180844,"marketCap":45529178},{"date":"2025-12-19","current":-1.715925,"twenty":-30.611139,"median":-26.302634,"eighty":-23.907328,"marketCap":36290687},{"date":"2025-12-26","current":-1.95203,"twenty":-30.454437,"median":-26.020087,"eighty":-4.901837,"marketCap":41454766},{"date":"2026-01-02","current":-1.640406,"twenty":-29.257892,"median":-25.860133,"eighty":-2.141062,"marketCap":34928602},{"date":"2026-01-09","current":-1.729279,"twenty":-28.740158,"median":-25.425778,"eighty":-1.946053,"marketCap":36871054},{"date":"2026-01-16","current":-1.697767,"twenty":-28.349603,"median":-25.256593,"eighty":-1.819317,"marketCap":36290687},{"date":"2026-01-23","current":-1.636148,"twenty":-28.159927,"median":-25.188071,"eighty":-1.77506,"marketCap":34940446},{"date":"2026-01-30","current":-1.222508,"twenty":-27.840038,"median":-24.733658,"eighty":-1.723937,"marketCap":26199412},{"date":"2026-02-06","current":-1.21961,"twenty":-27.608521,"median":-23.052212,"eighty":-1.690555,"marketCap":26175724},{"date":"2026-02-13","current":-1.297697,"twenty":-27.413697,"median":-4.901837,"eighty":-1.639593,"marketCap":27999733}],"updateTime":1771163989335},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"POM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608868155","title":"Pomdoctor Limited Announces Receipt of Nasdaq Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2608868155","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608868155?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:00","pubTimestamp":1770030001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA69FMCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","POM"],"gpt_icon":0},{"id":"2603991801","title":"Press Release: POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991801","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603991801?lang=en_us&edition=fundamental","pubTime":"2026-01-16 22:00","pubTimestamp":1768572000,"startTime":"0","endTime":"0","summary":"GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED  , a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability.Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented, \"China's rapidly expanding online pharmaceutical sales market offers significant development opportunities not only for pharmaceutical manufacturers seeking scalable and efficient distribution channels, but also for healthcare service platform operators. Our flexible collaboration models create win-win outcomes for both Pomdoctor and our pharmaceutical partners by effectively integrating the strengths of each party in a cost-efficient ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","CAGR","BK4175","BK4159"],"gpt_icon":0},{"id":"2589859522","title":"Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2589859522","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589859522?lang=en_us&edition=fundamental","pubTime":"2025-12-05 08:37","pubTimestamp":1764895028,"startTime":"0","endTime":"0","summary":"Pomdoctor (POM) opened H1 2025 with revenue of CNY 192.4 million and basic EPS of CNY -1.49, while the latest trailing twelve month figures show revenue of CNY 342.6 million and EPS of CNY -3.79. The company has seen revenue move from CNY 177.0 million in H2 2023 to CNY 192.4 million in H2 2024, with net income excluding extra items shifting from CNY -71.3 million to CNY -76.6 million over the same period, setting up a story where investors are weighing top line momentum against still...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor/news/pomdoctor-pom-losses-persist-as-price-to-sales-premium-tests","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor/news/pomdoctor-pom-losses-persist-as-price-to-sales-premium-tests","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["POM"],"gpt_icon":1},{"id":"2588249350","title":"Pomdoctor H1 EPS $(1.60), Sales $24.400M","url":"https://stock-news.laohu8.com/highlight/detail?id=2588249350","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588249350?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:28","pubTimestamp":1764797332,"startTime":"0","endTime":"0","summary":"Pomdoctor (NASDAQ:POM) reported quarterly losses of $(1.60) per share.  The company reported $24.400 million in sales this quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49197108/pomdoctor-h1-eps-1-60-sales-24-400m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","BK4175","POM",".IXIC","TSYW.SI","QLD","PSQ","USAW.SI","USJW.SI","NVIW.SI","NQmain","MNQmain","TQQQ","SQQQ"],"gpt_icon":0},{"id":"2588702487","title":"Pomdoctor Ltd. HY net loss attributable to shareholders at USD 66.7 million, down over six times","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702487","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588702487?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:16","pubTimestamp":1764796576,"startTime":"0","endTime":"0","summary":"Pomdoctor Ltd. reported its unaudited financial results for the first half  of fiscal 2025. The company posted a net loss of USD 14.0 million for the period. Net loss attributable to shareholders was USD 66.7 million. Total comprehensive loss reached USD 14.0 million for the first half of 2025. Cash paid for interest expense amounted to USD 1.1 million. The figures reflect the company's ongoing efforts in market expansion and revenue diversification amid a challenging macroeconomic environment and intensified competition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via PR Newswire  on December 03, 2025, and is solely responsible for the information contai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL8T7ZNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2588248710","title":"Press Release: POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588248710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588248710?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:15","pubTimestamp":1764796500,"startTime":"0","endTime":"0","summary":"GUANGZHOU, China, Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited  , a leading online medical services platform for chronic diseases in China, today announced its unaudited financial results for the six months ended June 30, 2025.Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: \"The first half of fiscal year 2025 reflected our deliberate and disciplined efforts to balance business expansion with operational rigor. Despite a challenging macroeconomic environment and intensified market competition, we strived to strengthen our market coverage and penetration, while optimizing and diversifying our revenue streams through the vigorous promotion of our internet-hospital services and online sales. During the period, we continued to solidify our partner-doctor pool by offering higher service fees, and at the same time meaningfully enhanced our collaboration with pharmaceutical manufacturers to drive online sales and adapt to China's evolving healthcare landscape.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","IPO","POM"],"gpt_icon":0},{"id":"2574122217","title":"PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574122217","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574122217?lang=en_us&edition=fundamental","pubTime":"2025-10-10 17:57","pubTimestamp":1760090220,"startTime":"0","endTime":"0","summary":"The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million. Just last month wewrote abouta Chinese company that suddenly decided to supersize its Nasdaq IPO in response to a looming new rule designed to weed out small – and often suspicious – new listings by foreign firms. But another company, internet-based healthcare providerPomDoctor Ltd., ignored those pending changes, proceeding with a listing plan that didn't seem to comply with the new rules.At $4 per ADS, the listing raised about $20 million, which would have violated the new Nasdaq rule requiring the $25 million minimum. And if the shares ultimately fall sharply, which could happen due to a valuation that looks quite aggressive, the company could also be subject to the proposed rule creating an expedited delisting process for any foreign company whose share float falls below","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/10/PomDoc-1010-900x600-1.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/10/PomDoc-1010-900x600-1.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/25/10/48143238/pomdoctor-debuts-on-nasdaq-ahead-of-new-listing-rules","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/25/10/48143238/pomdoctor-debuts-on-nasdaq-ahead-of-new-listing-rules","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["QID","TSYW.SI","POM","QLD",".IXIC","TQQQ","SQQQ","NVIW.SI","USAW.SI","NQmain","USJW.SI","PSQ","MNQmain"],"gpt_icon":1},{"id":"1117053116","title":"US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1117053116","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117053116?lang=en_us&edition=fundamental","pubTime":"2025-10-09 15:50","pubTimestamp":1759996218,"startTime":"0","endTime":"0","summary":"On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88. PomDoctor went...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","03086","QID","QQQ","TQQQ","POM","QLD","NVIW.SI","USAW.SI","NQmain","PSQ","NDX","USJW.SI",".IXIC","TSYW.SI","BK1147","MNQmain","159632","BK4007","ARTL"],"gpt_icon":0},{"id":"1177077314","title":"Stock Track | PomDoctor Plunges 7.90% After Hours Following Volatile IPO Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1177077314","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177077314?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:56","pubTimestamp":1759964179,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock plummet 7.90% in after-hours trading on Wednesday, following a tumultuous debut on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"1128958443","title":"Stock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1128958443","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128958443?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:00","pubTimestamp":1759960851,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"1159914910","title":"Stock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159914910","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159914910?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:00","pubTimestamp":1759960831,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"1125137890","title":"Stock Track | PomDoctor Plummets 6.25% on IPO Day Despite Initial Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1125137890","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125137890?lang=en_us&edition=fundamental","pubTime":"2025-10-09 03:52","pubTimestamp":1759953143,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, experienced a rollercoaster debut on the Nasdaq stock market on Wednesday. After initially rising 5%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"1142002700","title":"Stock Track | PomDoctor Plummets 6.25% After Initial IPO Surge, Investors Reassess","url":"https://stock-news.laohu8.com/highlight/detail?id=1142002700","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142002700?lang=en_us&edition=fundamental","pubTime":"2025-10-09 03:52","pubTimestamp":1759953140,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock plummet 6.25% in intraday trading on Wednesday, following an initial surge in its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"1159154155","title":"Stock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159154155","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159154155?lang=en_us&edition=fundamental","pubTime":"2025-10-08 23:36","pubTimestamp":1759937781,"startTime":"0","endTime":"0","summary":"PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["POM"],"gpt_icon":0},{"id":"2573250719","title":"Pomdoctor Prices Roughly $20 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573250719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573250719?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:59","pubTimestamp":1759928388,"startTime":"0","endTime":"0","summary":"Pomdoctor said Wednesday it has priced an initial public offering of about 5 million American depositary shares at $4 apiece for expected gross proceeds of roughly $20 million.The company said it has received approval for its ADSs to be listed on Nasdaq, adding that it expects its shares to start trading on Oct. 8 under the \"POM\" ticker symbol.The offering will likely close around Thursday, said Pomdoctor, which has provided the underwriters an option to acquire up to an additional 750,000 ADSs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["POM"],"gpt_icon":0},{"id":"2573236789","title":"BRIEF-Pomdoctor Limited Announces Pricing Of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2573236789","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573236789?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:20","pubTimestamp":1759926002,"startTime":"0","endTime":"0","summary":"BRIEF-Pomdoctor Limited Announces Pricing Of Initial Public OfferingOct 8 (Reuters) - PomDoctor Ltd POM.O:POMDOCTOR LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERINGPOMDOCTOR LTD - PRICING OF IPO O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUABGLPRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM"],"gpt_icon":0},{"id":"2573928490","title":"Pomdoctor Ltd: Approved for Listing on Nasdaq Under Ticker Symbol \"Pom\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928490?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:01","pubTimestamp":1759924863,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUABGLPRG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM"],"gpt_icon":0},{"id":"2573928483","title":"Pomdoctor Limited Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928483","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928483?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:01","pubTimestamp":1759924863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUABGLPRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM"],"gpt_icon":0},{"id":"2573416928","title":"Pomdoctor Ltd - Pricing of IPO of 5,000,004 Adss at a Public Offering Price of US$4.00 per Ads","url":"https://stock-news.laohu8.com/highlight/detail?id=2573416928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573416928?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:01","pubTimestamp":1759924863,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nTUABGLPRG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM"],"gpt_icon":0},{"id":"2569773368","title":"Polyplastics' DURAST (R) Fine Powder Technology Unleashes New Manufacturing Possibilities for Engineering Plastics","url":"https://stock-news.laohu8.com/highlight/detail?id=2569773368","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569773368?lang=en_us&edition=fundamental","pubTime":"2025-09-24 13:00","pubTimestamp":1758690000,"startTime":"0","endTime":"0","summary":"TOKYO, Sept. 24, 2025 /PRNewswire/ -- Polyplastics Group, a global leader in engineering thermoplastics, has announced the introduction of DURAST  Powder technology which transforms high-performance resins into fine powders, enabling the use of diverse manufacturing processes from prototyping to 3D printing and mass production.The DURAST Powder technology successfully micronizes high-strength, high-molecular-weight resins -- which were previously difficult to powder -- into various shapes such as spherical or fibrous forms based on application requirements. In particular, high-performance resins like liquid crystal polymer  and polyphenylene sulfide faced challenges with conventional grinding methods, such as particle agglomeration and reduced flowability. Using Polyplastics' proprietary technology, DURAST Powder achieves uniform powderization with an average particle size of approximately 1-100 micrometers for LCP. This powder exhibits excellent powder flowability and mixing dispersib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/polyplastics-durast-r-fine-powder-technology-unleashes-new-manufacturing-possibilities-for-engineering-plastics-302565303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","POM","BK7016","BK7503","PBT","R","PPS","BK4213","PPS.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}